切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (05) : 287 -290. doi: 10.3877/cma.j.issn.2095-3232.2014.05.007

所属专题: 文献

临床研究

Cylex ImmuKnow免疫细胞功能检测在肝移植术后感染诊断中的价值
黄小慧1, 许颖君1, 施巧素1, 张琪1, 易慧敏2,()   
  1. 1. 510630 广州,中山大学附属第三医院广东省肝脏疾病研究重点实验室
    2. 510630 广州,中山大学附属第三医院外科重症监护病房
  • 收稿日期:2014-05-07 出版日期:2014-10-10
  • 通信作者: 易慧敏
  • 基金资助:
    国家十二五科技重大专项课题(2012ZX10002010-001-007); 广东省科技计划项目(2009A030200006); 广州市科技计划项目(2010J-E121,2010U1-E00551-1)

Cylex ImmuKnow immune cell function assay in the diagnosis of infection after liver transplantation

Xiaohui Huang1, Yingjun Xu1, Qiaosu Shi1, Qi Zhang1, Huimin Yi2,()   

  1. 1. Guangdong Provincial Key Laboratory of Liver Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2014-05-07 Published:2014-10-10
  • Corresponding author: Huimin Yi
  • About author:
    Corresponding author: Yi Huimin, Email:
引用本文:

黄小慧, 许颖君, 施巧素, 张琪, 易慧敏. Cylex ImmuKnow免疫细胞功能检测在肝移植术后感染诊断中的价值[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(05): 287-290.

Xiaohui Huang, Yingjun Xu, Qiaosu Shi, Qi Zhang, Huimin Yi. Cylex ImmuKnow immune cell function assay in the diagnosis of infection after liver transplantation[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(05): 287-290.

目的

探讨Cylex ImmuKnow免疫细胞功能检测在肝移植术后感染诊断中的价值。

方法

前瞻性研究对象为2010年7月至2012年12月在中山大学附属第三医院肝移植中心接受同种异体原位肝移植术的48例患者。所有患者均签署知情同意书,符合医学伦理学规定。根据肝移植术后有否临床感染将患者分为感染组(14例)、非感染组(34例),另设健康对照组(对照组,20例)。其中感染组男11例,女3例,平均年龄(47±10)岁;非感染组男29例,女5例,年龄(45±9)岁;对照组男10例,女10例,年龄(42±10)岁。患者肝移植术后7 d和对照组入组时,抽取外周静脉血2 ml,应用Cylex ImmuKnow免疫细胞功能测定试剂盒检测分化群(CD)4+淋巴细胞的三磷酸腺苷(ATP)含量,检测数据比较采用t检验。

结果

感染组、非感染组和对照组的ATP含量分别为(178±58)、(345±62)、(467±84)mg/L,感染组ATP含量明显低于非感染组(t=-4.6,P<0.05)。Cylex ImmuKnow免疫细胞功能检测诊断肝移植术后感染的灵敏度为0.79,特异度为0.85;阳性预测值为0.69,阴性预测值为0.91。

结论

Cylex ImmuKnow免疫细胞功能检测能够简便、快速检测患者免疫细胞功能水平,对肝移植术后感染具有一定的监测和诊断价值。

Objective

To investigate the value of Cylex ImmuKnow immune cell function assay in the diagnosis of infection after liver transplantation.

Methods

The objects of this prospective study were 48 patients undergoing orthotopic liver transplantation (OLT) in Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University from July 2010 to December 2012. The informed consents of all patients were obtained and the ethical committee approval was received. According to whether the patients suffered clinical infection or not after OLT, they were divided into two groups: infection group (n=14) and non-infection group (n=34). Another 20 healthy people were enrolled as the control group. There were 11 males and 3 females in the infection group with a mean age of (47±10) years old. There were 29 males and 5 females in the non-infection group with a mean age of (45±9) years old. There were 10 males and 10 females in the control group with a mean age of (42±10) years old. Peripheral venous blood 2 ml was collected from the patients on the 7th day after OLT or from the healthy people when enrolled in control group. The adenosine triphosphate (ATP) level in cluster of differentiation (CD) 4+ lymphocyte was detected using Cylex ImmuKnow kit and the testing data were compared using t test.

Results

The ATP level in CD4+ cells was (178±58), (345±62), (467±84) mg/L in infection group, non-infection group and control group respectively. The ATP level in infection group was significantly lower than that in non-infection group (t =-4.6, P<0.05). The sensitivity of the Cylex ImmuKnow immune cell function assay in the diagnosis of infection after OLT was 0.79, the specificity was 0.85, the positive predictive value was 0.69, and the negative predictive value was 0.91.

Conclusions

Cylex ImmuKnow immune cell function assay can simply and quickly detect the immune cell function. It plays a role in monitoring and diagnosing the infection after OLT.

表1 Cylex ImmuKnow免疫细胞功能检测对肝移植术后感染的诊断试验结果(例)
[1]
Israeli M, Ben-Gal T, Yaari V, et al. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests[J]. Transplantation, 2010, 89(8):968-976.
[2]
Shapiro R. End-stage renal disease in 2010: innovative approaches to improve outcomes in transplantation[J]. Nat Rev Nephrol, 2011, 7(2):68-70.
[3]
Brick C, Atouf O, Benseffaj N, et al. Rejection of kidney graft: mechanism and prevention[J]. Nephrol Ther, 2011, 7(1):18-26.
[4]
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009, 9 Suppl 3:S1-155.
[5]
Wieland E, Olbricht CJ, Süsal C, et al. Biomarkers as a tool for management of immunosuppression in transplant patients[J]. Ther Drug Monit, 2010, 32(5):560-572.
[6]
Budde K, Matz M, Dürr M, et al. Biomarkers of over-immunosuppression[J]. Clin Pharmacol Ther, 2011, 90(2):316-322.
[7]
Sommerer C, Zeier M, Meuer S, et al. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients[J]. Transplantation, 2010, 89(11):1417-1423.
[8]
Sommerer C, Schnitzler P, Meuer S, et al. Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older[J]. Ther Drug Monit, 2011, 33(6):694-698.
[9]
Uemura T, Riley TR, Khan A, et al. Immune functional assay for immunosuppressive management in post-transplant malignancy[J]. Clin Transplant, 2011, 25(1):E32-37.
[10]
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies[J]. Ann Intern Med, 2011, 155(8):529-536.
[11]
Zhou T, Xue F, Han LZ, et al. Invasive fungal infection after liver transplantation: risk factors and significance of immune cell function monitoring[J]. J Dig Dis, 2011, 12(6):467-475.
[12]
Cheng JW, Shi YH, Fan J, et al. An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2011, 137(10):1445-1453.
[13]
Dong JY, Yin H, Li RD, et al. The relationship between adenosine triphosphate within CD4(+) T lymphocytes and acute rejection after liver transplantation[J]. Clin Transplant, 2011, 25(3):E292-296.
[14]
Mizuno S, Hamada T, Nakatani K, et al. Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype[J]. J Hepatobiliary Pancreat Sci, 2011, 18(2):226-232.
[15]
Fishman JA. Infection in solid-organ transplant recipients[J]. N Engl J Med, 2007, 357(25):2601-2614.
[16]
Husain S, Raza K, Pilewski JM, et al. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection[J]. Transplantation, 2009, 87(12):1852-1857.
[17]
Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risk of infection and rejection: a meta-analysis using an immune function assay[J]. Transplantation, 2006, 82(5):663-668.
[18]
Xue F, Zhang J, Han L, et al. Immune cell function assay in monitoring of adult liver transplantation recipients with infection[J]. Transplantation,2010, 89(5):620-626.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[3] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[4] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[5] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[6] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[7] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[9] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[10] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[11] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[12] 傅斌生, 冯啸, 杨卿, 曾凯宁, 姚嘉, 唐晖, 刘剑戎, 魏绪霞, 易慧敏, 易述红, 陈规划, 杨扬. 脂肪变性供肝在成人劈离式肝移植中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 789-794.
[13] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[14] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?